Discover 1,474 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,474
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Seattle WA, Portland OR, Boise ID, Sacramento CA,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701669
Phase 2, Recruiting
TVMR With the INNOVALVE System Trial - Early Feasibility Study
for
Mitral Valve Regurgitation (Degenerative or Functional)
Location: Seattle WA, Portland OR, Palo Alto CA, Los Angeles CA,
Sponsor: Edwards Lifesciences
Sex: All
Age: 18+
Code: NCT04919980
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
for
Adjustment Disorder
Location: Seattle WA, Draper UT, Aurora CO, San Diego CA,
Sponsor: Reunion Neuroscience Inc
Sex: All
Age: 18 - 70+
Code: NCT07002034
Phase 2, Recruiting
The OBSERVE Protocol
for
Major Depression Disorder
Location: Seattle WA, Bellaire TX, Nashville TN, Atlanta GA,
Sponsor: Yale University
Sex: All
Age: 0+
Code: NCT06725277
Recruiting
Resistance to HIV Infection
for
HIV Infections
Location: Seattle WA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 60
Code: NCT00069485
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
for
HIV
Location: Seattle WA, Birmingham AL, Atlanta GA, Boston MA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 60
Code: NCT07569029
Phase 1, Recruiting
Dasatinib for HIV-1 Reservoir Reduction
for
HIV Infections
Location: Seattle WA, Chicago IL, Cleveland OH
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18+
Code: NCT07342491
Phase 1, Recruiting
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
for
HIV Infections
Location: Seattle WA, San Francisco CA, Kansas City MO, Dallas TX,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07682961
Phase 3, Recruiting
New
Effectiveness and Safety of TachoSil® Fibrin Sealant Patch for Supporting Dural Sealing Among Adult Inpatients
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)
for
AML, Adult
Location: Seattle WA, Los Angeles CA, Houston TX,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18 - 70+
Code: NCT04964518
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
for
Metastatic Breast Cancer
Location: Seattle WA, Kennewick WA, Calgary, Burbank CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05894239
Phase 3, Recruiting
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Regional Kidney Paired Donor Exchange in Sensitized Patients
for
The Rate of Kidney Transplants in Sensitized Patients.
Location: Seattle WA
Sponsor: BiologicTx, LLC
Sex: All
Age: 18+
Code: NCT01896089
Recruiting
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
for
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC),
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
for
Renal Cell Carcinoma
Location: Seattle WA, Los Angeles CA, Aurora CO, Lone Tree CO,
Sponsor: HiberCell, Inc.
Sex: All
Age: 18+
Code: NCT06234605
Phase 1, Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Relapsed and/or Refractory Multiple Myeloma
Location: Seattle WA, San Francisco CA, Stanford CA, Duarte CA,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06153251
Phase 1, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Seattle WA, Edmonds WA, Vancouver WA, Portland OR,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase 3, Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
for
Aortic Stenosis, Calcific, Aortic Valve Stenosis
Location: Seattle WA, Portland OR, Boise ID, San Francisco CA,